<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Control</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Control</journal-id><journal-id journal-id-type="pmc-domain-id">3344</journal-id><journal-id journal-id-type="pmc-domain">ccon</journal-id><journal-id journal-id-type="publisher-id">CCX</journal-id><journal-title-group><journal-title>Cancer Control : Journal of the Moffitt Cancer Center</journal-title></journal-title-group><issn pub-type="ppub">1073-2748</issn><issn pub-type="epub">1526-2359</issn><publisher><publisher-name>SAGE Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10399273</article-id><article-id pub-id-type="pmcid-ver">PMC10399273.1</article-id><article-id pub-id-type="pmcaid">10399273</article-id><article-id pub-id-type="pmcaiid">10399273</article-id><article-id pub-id-type="pmid">37528552</article-id><article-id pub-id-type="doi">10.1177/10732748231193243</article-id><article-id pub-id-type="publisher-id">10.1177_10732748231193243</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Research Article</subject></subj-group></article-categories><title-group><article-title>Adenoma Detection Rate in Average-Risk Population: An Observational Consecutive Retrospective Study</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4760-1789</contrib-id><name name-style="western"><surname>He</surname><given-names initials="X">Xiaoyan</given-names></name><degrees>MD</degrees><xref rid="aff1-10732748231193243" ref-type="aff">1</xref><xref rid="fn1-10732748231193243" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0005-8207-4912</contrib-id><name name-style="western"><surname>Lv</surname><given-names initials="X">Xiangyin</given-names></name><degrees>MD</degrees><xref rid="aff1-10732748231193243" ref-type="aff">1</xref><xref rid="fn1-10732748231193243" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0006-9783-6120</contrib-id><name name-style="western"><surname>Zhang</surname><given-names initials="B">Binbin</given-names></name><degrees>MD</degrees><xref rid="aff1-10732748231193243" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0004-4177-6267</contrib-id><name name-style="western"><surname>Ying</surname><given-names initials="X">Xiaoxuan</given-names></name><degrees>MD</degrees><xref rid="aff1-10732748231193243" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0001-6858-5450</contrib-id><name name-style="western"><surname>Hu</surname><given-names initials="C">Chiyu</given-names></name><degrees>MD</degrees><xref rid="aff1-10732748231193243" ref-type="aff">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6529-0243</contrib-id><name name-style="western"><surname>Zhou</surname><given-names initials="X">Xiaoying</given-names></name><degrees>PhD</degrees><xref rid="aff2-10732748231193243" ref-type="aff">2</xref><xref rid="corresp1-10732748231193243" ref-type="corresp"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1239-7151</contrib-id><name name-style="western"><surname>Hu</surname><given-names initials="J">Jianwen</given-names></name><degrees>MD</degrees><xref rid="aff1-10732748231193243" ref-type="aff">1</xref><xref rid="corresp2-10732748231193243" ref-type="corresp"/></contrib><aff id="aff1-10732748231193243"><label>1</label>Department of Gastroenterology, <institution-wrap><institution content-type="university">Dongyang Hospital affiliated to Wenzhou Medical University</institution></institution-wrap>, Dongyang, China</aff><aff id="aff2-10732748231193243"><label>2</label>Department of Gastroenterology, <institution-wrap><institution content-type="university">The First Affiliated Hospital of Nanjing Medical University</institution></institution-wrap>, Nanjing, China</aff></contrib-group><author-notes><corresp id="corresp1-10732748231193243">Xiaoying Zhou, PhD, Department of Gastroenterology, First Affiliated hospital of Nanjing medical university, 300# Guangzhou Road, 210029, Nanjing, China. Email: <email>zhouxiaoying0926@sina.cn</email></corresp><corresp id="corresp2-10732748231193243">Jianwen Hu, MD, Department of Gastroenterology, Dongyang Hospital affiliated to Wenzhou Medical University, 60# Wuningxi Road, 322100, Jinhua, Zhejiang, China. Email: <email>hujianwen1962@163.com</email></corresp><fn fn-type="equal" id="fn1-10732748231193243"><label>*</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>1</day><month>8</month><year>2023</year></pub-date><pub-date pub-type="collection"><season>Jan-Dec</season><year>2023</year></pub-date><volume>30</volume><issue-id pub-id-type="pmc-issue-id">425778</issue-id><elocation-id>10732748231193243</elocation-id><history><date date-type="received"><day>18</day><month>1</month><year>2023</year></date><date date-type="rev-recd"><day>6</day><month>6</month><year>2023</year></date><date date-type="accepted"><day>11</day><month>7</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>08</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>04</day><month>08</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-08-04 12:25:09.487"><day>04</day><month>08</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder content-type="sage">SAGE Publications Inc, unless otherwise noted. Manuscript content on this site is licensed under Creative Common Licences</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10.1177_10732748231193243.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="1193243.pdf"/><abstract><sec><title>Background</title><p>Although colonoscopy is considered the most effective tool for reducing colorectal cancer-related morbidity, the age at which average-risk individuals begin colonoscopic screening is undetermined. This study aimed to compare the adenoma and advanced adenoma detection rates according to age and sex in a large average-risk population in the rural areas of Eastern China.</p></sec><sec><title>Methods</title><p>This observational, single-center, retrospective study included patients with average colorectal cancer risk and examined the adenoma and advanced adenoma detection rates using age intervals of 5&#160;years. We also compared the size and age of patients with and without advanced adenoma.</p></sec><sec><title>Results</title><p>We included 18&#160;928 patients with a median age of 54 years (range 15&#8211;90&#160;years), including 10&#160;143 men and 8785 women. The adenoma and advanced adenoma detection rates were 17.08% and 5.24%, respectively, and increased with age in the whole population. The adenoma detection rates increased from 8.97% (aged 40&#8211;44) to 14.98% (aged 45&#8211;49) and 6.24% (aged 45&#8211;49) to 11.00% (aged 50&#8211;54) in men and women (both <italic toggle="yes">P</italic> &lt; .001), respectively. The advanced adenoma detection rates increased from 2.19% (aged 40&#8211;44) to 4.76% (aged 45&#8211;49) and 1.89% (aged 45&#8211;49) to 3.13% (aged 50&#8211;54) in men (<italic toggle="yes">P</italic> = .002) and women (<italic toggle="yes">P</italic> = .056), respectively. Patients with advanced adenomas were significantly older than those with non-advanced adenomas (<italic toggle="yes">P</italic> &lt; .001). The tumors in the advanced adenoma group were significantly larger than those in the non-advanced adenoma group (<italic toggle="yes">P</italic> &lt; .001).</p></sec><sec><title>Conclusion</title><p>The adenoma and advanced adenoma detection rates increased significantly in average-risk population aged 45&#160;years and older, especially in men.</p></sec></abstract><kwd-group><kwd>colorectal cancer</kwd><kwd>average-risk</kwd><kwd>adenoma detection rate</kwd><kwd>advanced adenoma detection rate</kwd><kwd>colonoscopy</kwd></kwd-group><funding-group specific-use="FundRef"><award-group id="award1-10732748231193243"><funding-source id="funding1-10732748231193243"><institution-wrap><institution>National Natural Science Foundation of China</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id rid="funding1-10732748231193243">82100594</award-id></award-group><award-group id="award2-10732748231193243"><funding-source id="funding2-10732748231193243"><institution-wrap><institution>The medical and health research project of Zhejiang province</institution></institution-wrap></funding-source><award-id rid="funding2-10732748231193243">2022KY429</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>typesetter</meta-name><meta-value>ts10</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January-December 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec5-10732748231193243"><title>Introduction</title><p>Colorectal cancer (CRC) is one of the most common cancers worldwide, with significantly increased morbidity and mortality rates in China over the last few decades.<sup><xref rid="bibr1-10732748231193243" ref-type="bibr">1</xref>,<xref rid="bibr2-10732748231193243" ref-type="bibr">2</xref></sup> The etiopathogenesis of most CRCs follows a sequence of events that have been described as the adenoma-carcinoma sequence.<sup><xref rid="bibr3-10732748231193243" ref-type="bibr">3</xref>,<xref rid="bibr4-10732748231193243" ref-type="bibr">4</xref></sup> This sequence typically takes more than 10&#160;years to complete in sporadic cancers and can be effectively disrupted via screening.<sup>
<xref rid="bibr5-10732748231193243" ref-type="bibr">5</xref>
</sup> Colonoscopy is considered the most efficacious screening method for reducing CRC incidence and mortality because it allows for the early detection and removal of precancerous polyps and the detection of early-stage CRC.<sup><xref rid="bibr1-10732748231193243" ref-type="bibr">1</xref>,<xref rid="bibr6-10732748231193243" ref-type="bibr">6</xref></sup> The US Multi-Society Task Force (MSTF) for colorectal cancer recommends initiating CRC screening at 50&#160;years of age in average-risk populations, except African Americans, who should begin screening at 45&#160;years of age.<sup>
<xref rid="bibr5-10732748231193243" ref-type="bibr">5</xref>
</sup> The National Cancer Center of China also recommends screening for CRC starting at the age of 50&#160;years for average-risk individuals, but the screening options vary widely.<sup>
<xref rid="bibr7-10732748231193243" ref-type="bibr">7</xref>
</sup> Owing to the discomfort, complications, and cost of a colonoscopy, it is rarely used for initial screening in the average-risk population.<sup>
<xref rid="bibr7-10732748231193243" ref-type="bibr">7</xref>
</sup> Previous study showed that colorectal adenoma and advanced neoplasia detection rates increase from 45&#160;years of age in the European population.<sup>
<xref rid="bibr8-10732748231193243" ref-type="bibr">8</xref>
</sup> However, reliable data on the risk of precancerous polyps and early-stage CRC in other populations are rare, especially in average-risk individuals under 50.<sup><xref rid="bibr5-10732748231193243" ref-type="bibr">5</xref>,<xref rid="bibr7-10732748231193243" ref-type="bibr">7</xref></sup> This makes it difficult to recommend an appropriate age for colonoscopic screening in average-risk populations.</p><p>The incidences of CRC and adenoma vary according to age, sex, and region.<sup><xref rid="bibr9-10732748231193243" ref-type="bibr">9</xref>-<xref rid="bibr11-10732748231193243" ref-type="bibr">11</xref></sup> To improve the time- and cost-effectiveness of colonoscopy and reduce complications, it is worth discussing the age at which screening using colonoscopy is initiated in different regions and sexes.</p><p>This study aimed to determine the adenoma detection rate (ADR) and advanced adenoma detection rate (AADR) according to age and sex in a large average-risk population of consecutive patients admitted to our digestive endoscopy unit for colonoscopy in the rural areas of Eastern China.</p></sec><sec sec-type="materials|methods" id="sec6-10732748231193243"><title>Materials and Methods</title><p>This observational, single-center, continuous retrospective study was conducted at our hospital from January 1, 2019, to March 31, 2022. This study conformed to STROBE guidelines.<sup>
<xref rid="bibr12-10732748231193243" ref-type="bibr">12</xref>
</sup> All patients were informed about the use of their endoscopic data for clinical research purposes. Data were retrospectively collected from the medical patient management software. All patient details have been de-identified. All authors declare that they have access to the study data and have reviewed and approved the final manuscript.</p><sec id="sec7-10732748231193243"><title>Patients</title><p>All consecutive patients scheduled for colonoscopy at our hospital from January 1, 2019, to December 31, 2021, were included. Based on the Chinese guidelines for the screening, early detection, and treatment of CRC,<sup>
<xref rid="bibr7-10732748231193243" ref-type="bibr">7</xref>
</sup> patients who were at average risk of CRC were included. Patients with none of the following risk factors were considered average-risk patients for CRC: 1. first-degree relatives with CRC (including a family history of non-hereditary CRC and family history of hereditary CRC); 2. a history of CRC, 3. a history of colorectal adenoma, 4. a history 8&#8211;10&#160;years of active inflammatory bowel disease; and 5. positive fecal immunochemical test results. The exclusion criteria were as follows: 1. patients who did not undergo cecal intubation and 2. patients with polyps showing no pathological findings.</p></sec><sec id="sec8-10732748231193243"><title>Data Collection</title><p>The following data were collected: age, sex, polyp size, polyp histopathology, and the number of adenomas. If a patient had more than one polyp, the maximum diameter of the largest polyp was recorded. If a patient had both adenomas and non-adenomatous polyps, the maximum diameter of the adenoma was recorded.</p></sec><sec id="sec9-10732748231193243"><title>Colonoscopy Considerations</title><p>The following colonoscopes were used: H260AI, Q260AZI, CF-Q260AI, CF-HQ290I, and HQ290I (Olympus, Tokyo, Japan).</p></sec><sec id="sec10-10732748231193243"><title>Histopathological Considerations</title><p>An adenoma was defined as a tubular, tubulovillous, or villous adenoma.<sup>
<xref rid="bibr5-10732748231193243" ref-type="bibr">5</xref>
</sup> An advanced adenoma was defined as an adenoma with a size of &#8805;10&#160;mm, with tubulovillous or villous histology, or with high-grade dysplasia in the absence of invasive CRC.<sup>
<xref rid="bibr13-10732748231193243" ref-type="bibr">13</xref>
</sup> Sessile serrated lesions (SSLs) are hyperplastic polyps, sessile serrated adenomas/polyps, or traditional serrated adenomas. Sessile serrated adenomas/polyps and traditional serrated adenomas are also known as serrated adenomas.<sup>
<xref rid="bibr5-10732748231193243" ref-type="bibr">5</xref>
</sup> Inflammatory polyp was defined as non-neoplastic polypoid lesion of intestinal mucosal secondary to chronic nonspecific inflammatory diseases of the colorectal.<sup>
<xref rid="bibr14-10732748231193243" ref-type="bibr">14</xref>
</sup></p></sec><sec id="sec11-10732748231193243"><title>Statistical Analysis</title><p>Statistical analysis was performed using IBM SPSS Statistics for Windows, version 27.0. Quantitative and qualitative variables are expressed as median (interquartile range; IQR) and numbers (percentages), respectively. Continuous variables were compared using the Wilcoxon-Mann&#8211;Whitney U test or Kruskal&#8211;Wallis test. Categorical variables were compared using the chi-square test, CALIBRATION chi-square test, or Fisher&#8217;s exact test, as required. A <italic toggle="yes">P</italic>-value of &lt;.05 indicated a statistically significant difference.</p></sec></sec><sec sec-type="results" id="sec12-10732748231193243"><title>Results</title><p>A total of 18&#160;928 patients with a median age of 54&#160;years (range 15&#8211;90, IQR 20&#160;years), including 10&#160;143 men and 8785 women were included (<xref rid="table1-10732748231193243" ref-type="table">Table 1</xref>).<table-wrap position="float" id="table1-10732748231193243" orientation="portrait"><label>Table 1.</label><caption><p>Baseline Cohort Demographics and Screening Characteristics in the Whole Population.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="table1-10732748231193243" position="float" orientation="portrait" xlink:href="10.1177_10732748231193243-table1.jpg"/><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">N(%)</th><th align="center" rowspan="1" colspan="1">Median Age (range, IQR), yr</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th><th align="center" rowspan="1" colspan="1">Male n(%)</th><th align="center" rowspan="1" colspan="1">Female n(%)</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">18&#160;928</td><td align="char" char="(" rowspan="1" colspan="1">54(15-90, 20)</td><td align="left" rowspan="1" colspan="1"/><td align="char" char="(" rowspan="1" colspan="1">10&#160;143(53.59)</td><td align="char" char="(" rowspan="1" colspan="1">8785(46.41)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="7" rowspan="1">Colonoscopy result</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Polyps found</td><td align="left" rowspan="1" colspan="1">4774(25.22)</td><td align="char" char="(" rowspan="1" colspan="1">59(22-90, 16)</td><td align="char" char="." rowspan="2" colspan="1">&lt;.001</td><td align="char" char="(" rowspan="1" colspan="1">3082(30.39)</td><td align="char" char="(" rowspan="1" colspan="1">1692(19.26)</td><td align="char" char="." rowspan="2" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Polyps not found</td><td align="left" rowspan="1" colspan="1">14&#160;154(74.78)</td><td align="char" char="(" rowspan="1" colspan="1">52(15-89, 19)</td><td align="char" char="(" rowspan="1" colspan="1">7061(69.61)</td><td align="char" char="(" rowspan="1" colspan="1">7093(80.74)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Adenoma found</td><td align="left" rowspan="1" colspan="1">3232(17.08)</td><td align="char" char="(" rowspan="1" colspan="1">61(23-90, 15)</td><td align="char" char="." rowspan="2" colspan="1">&lt;.001</td><td align="char" char="(" rowspan="1" colspan="1">2089(20.60)</td><td align="char" char="(" rowspan="1" colspan="1">1143(13.01)</td><td align="char" char="." rowspan="2" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Adenoma not found</td><td align="left" rowspan="1" colspan="1">15&#160;696(82.92)</td><td align="char" char="(" rowspan="1" colspan="1">52(15-89, 19)</td><td align="char" char="(" rowspan="1" colspan="1">8054(79.40)</td><td align="char" char="(" rowspan="1" colspan="1">7642(86.99)</td></tr></tbody></table></alternatives></table-wrap></p><sec id="sec13-10732748231193243"><title>Results in the Whole Population</title><p>Of the 18&#160;929 patients, polyps were detected in 4774 patients with a median age of 59&#160;years (range 22&#8211;90, IQR 16). Polyps were not detected in the remaining 14&#160;154 patients with a median age of 52&#160;years (range 15&#8211;89, IQR 19). The polyp detection rate (PDR) was 25.22%. The age of the patients with polyps was significantly higher than that of those without polyps (<italic toggle="yes">P</italic> &lt; .001). The men-to-women ratio in patients with polyps was significantly higher than that in patients without polyps (3082/7061 and 1692/7093, respectively; <italic toggle="yes">P</italic> &lt; .001). Of the 18&#160;929 patients, adenomas were detected in 3232 patients with a median age of 61&#160;years (range 23&#8211;90, IQR 15), and adenomas were not detected in the remaining 15&#160;696 patients with a median age of 52&#160;years (range 15&#8211;89, IQR 19). The ADR was 17.08%. The age of the patients with adenomas was significantly higher than that of the patients without adenomas (<italic toggle="yes">P</italic> &lt; .001). The men-to-women ratio of patients with adenomas was significantly higher than that of patients without adenomas, at 2089/8054 and 1143/7642, respectively (<italic toggle="yes">P</italic> &lt; .001) (<xref rid="table1-10732748231193243" ref-type="table">Table 1</xref>).</p><p>Of the 3232 patients with adenomas, advanced adenomas were detected in 992 patients with a median age of 63&#160;years (range 26&#8211;90, IQR 15), and non-advanced adenomas were detected in 2240 patients with a median age of 60&#160;years (range 23&#8211;88, IQR 15). The AADR was 5.24%. Advanced adenomas accounted for 30.69% of all adenomas. Patients with advanced adenomas were significantly older than those with non-advanced adenomas (<italic toggle="yes">P</italic> &lt; .001). No significant difference was observed in the men-to-women ratio between the two groups (663/329 and 1426/814, respectively; <italic toggle="yes">P</italic> = .08). The size of advanced adenoma with a median diameter of 1.0&#160;cm (range .4&#8211;6.0, IQR .5) was significantly larger than that of non-advanced adenoma with a median diameter of .6&#160;cm (range .2&#8211;1.0, IQR .3) (<italic toggle="yes">P</italic> &lt; .001) (<xref rid="table2-10732748231193243" ref-type="table">Table 2</xref>).<table-wrap position="float" id="table2-10732748231193243" orientation="portrait"><label>Table 2.</label><caption><p>Comparative Analysis of Advanced and Non-advanced Adenomas.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="table2-10732748231193243" position="float" orientation="portrait" xlink:href="10.1177_10732748231193243-table2.jpg"/><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Advanced adenoma</th><th align="center" rowspan="1" colspan="1">Non-advanced adenoma</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">992</td><td align="left" rowspan="1" colspan="1">2240</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Male/Female(n%)</td><td align="left" rowspan="1" colspan="1">663/329</td><td align="left" rowspan="1" colspan="1">1426/814</td><td align="char" char="." rowspan="1" colspan="1">.082</td></tr><tr><td align="left" rowspan="1" colspan="1">Median Age (range, IQR), yr</td><td align="left" rowspan="1" colspan="1">63(26-90, 15)</td><td align="left" rowspan="1" colspan="1">60(23-88, 15)</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Median size (range, IQR), cm</td><td align="left" rowspan="1" colspan="1">1.0(.4-6.0, .5)</td><td align="left" rowspan="1" colspan="1">.6(.2-1.0, .3)</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td></tr></tbody></table></alternatives></table-wrap></p><p>Of the 3232 patients with adenoma, 2042 patients had one adenoma, 604 had two adenomas, and 586 had three or more adenomas, accounting for 63.18%, 18.69%, and 18.13%, respectively. The median age of patients with one, two, and three or more adenomas gradually increased to 59 (23&#8211;90, IQR 15), 62 (29&#8211;86, IQR 14), and 65 (26&#8211;88, IQR 14) years, respectively, with a statistical difference (<italic toggle="yes">P</italic> &lt; .01). The men-to-women ratios of patients with one, two, and three or more adenomas gradually increased to 1.51, 2.05, and 3.47, respectively (<italic toggle="yes">P</italic> &lt; .01), with a statistical difference (<xref rid="table3-10732748231193243" ref-type="table">Table 3</xref>).<table-wrap position="float" id="table3-10732748231193243" orientation="portrait"><label>Table 3.</label><caption><p>Comparison of Age and Gender Between Groups With Different Number of Adenomas.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="table3-10732748231193243" position="float" orientation="portrait" xlink:href="10.1177_10732748231193243-table3.jpg"/><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">Number of adenomas</th><th align="center" rowspan="1" colspan="1">N(%)</th><th align="center" rowspan="1" colspan="1">Median Age(range, IQR), yr</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th><th align="center" rowspan="1" colspan="1">Male/Female(n)</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">1</td><td align="char" char="(" rowspan="1" colspan="1">2042(63.18)</td><td align="char" char="(" rowspan="1" colspan="1">59(23-90, 15)</td><td align="char" char="." rowspan="2" colspan="1">&lt;.001</td><td align="char" char="." rowspan="1" colspan="1">1228/814</td><td align="char" char="." rowspan="2" colspan="1">.002</td></tr><tr><td align="left" rowspan="2" colspan="1">2</td><td align="char" char="(" rowspan="2" colspan="1">604(18.69)</td><td align="char" char="(" rowspan="2" colspan="1">62(29-86, 14)</td><td align="char" char="." rowspan="2" colspan="1">406/198</td></tr><tr><td align="char" char="." rowspan="2" colspan="1">.001</td><td align="char" char="." rowspan="2" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8805;3</td><td align="char" char="(" rowspan="1" colspan="1">586(18.13)</td><td align="char" char="(" rowspan="1" colspan="1">65(26-88, 14)</td><td align="char" char="." rowspan="1" colspan="1">455/131</td></tr></tbody></table></alternatives></table-wrap></p></sec><sec id="sec14-10732748231193243"><title>Results According to Age Intervals and Gender</title><p>We examined ADR and AADR according to age using age intervals of 5&#160;years. Both ADR and AADR increased significantly with age in the whole population in men and women (<xref rid="fig1-10732748231193243" ref-type="fig">Figure 1</xref>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://journals.sagepub.com/doi/suppl/10.1177/10732748231193243" ext-link-type="uri">Supplementary Figures 1 and 2</ext-link>). After the age of 45&#160;years, the growth rates of ADR and AADR increased significantly in the entire population (<xref rid="fig1-10732748231193243" ref-type="fig">Figure 1</xref>). The ADR markedly increased from 8.97% to 14.98% in male patients aged 40&#8211;44 and 45&#8211;49&#160;years (<italic toggle="yes">P</italic> &lt; .001), whereas no significant difference was observed in ADR between male patients aged 35&#8722;39&#160;years and 40&#8211;44&#160;years (6.72% vs 8.97%, <italic toggle="yes">P</italic> = .08) (<xref rid="fig2-10732748231193243" ref-type="fig">Figure 2(A)</xref>). The ADR markedly increased from 6.24% to 11.00% among female patients aged 45&#8722;49 and 50&#8722;54&#160;years (<italic toggle="yes">P</italic> &lt; .001), whereas no significant difference was detected in the ADR between female patients aged 40&#8211;44 and 45&#8211;49&#160;years (6.07% vs 6.24%, <italic toggle="yes">P</italic> = .88) (<xref rid="fig2-10732748231193243" ref-type="fig">Figure 2(B)</xref>).<fig position="float" fig-type="figure" id="fig1-10732748231193243" orientation="portrait"><label>Figure 1.</label><caption><p>(A) Adenoma detection rate according to age in the whole population. (B) Advanced adenoma detection rate according to age in the whole population.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_10732748231193243-fig1.jpg"/></fig><fig position="float" fig-type="figure" id="fig2-10732748231193243" orientation="portrait"><label>Figure 2.</label><caption><p>(A) Adenoma detection rate in the 35&#8211;39, 40&#8211;44, and 45&#8211;49 age groups in men. (B) Adenoma detection rate in the 40&#8211;44, 45&#8211;49, and 50&#8211;54 age groups in women. (C) Advanced adenoma detection rate in the 35&#8211;39, 40&#8211;44, and 45&#8211;49 age groups in men. (D) Advanced adenoma detection rate in the 40&#8211;44, 45&#8211;49, and 50&#8211;54 age groups in women.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_10732748231193243-fig2.jpg"/></fig></p><p>The AADR markedly increased from 2.19% to 4.76% between male patients aged 40&#8211;44 and 45&#8211;49&#160;years (<italic toggle="yes">P</italic> = .002), while no significant difference was observed in the AADR between male patients aged 35&#8211;39 and 40&#8211;44 (1.30% vs 2.19%, <italic toggle="yes">P</italic> = .16) (<xref rid="fig2-10732748231193243" ref-type="fig">Figure 2(C)</xref>). The AADR increased from 1.89% to 3.13% in female patients aged 45&#8211;49 and 50&#8211;54&#160;years, but no statistical difference was observed between the two groups (<italic toggle="yes">P</italic> = .056). And there was also no significant difference in the AADR between female patients aged 40&#8211;44 and 45&#8211;49 (1.42% vs 1.89%, <italic toggle="yes">P</italic> = .44) (<xref rid="fig2-10732748231193243" ref-type="fig">Figure 2(D)</xref>).</p><p>In 35&#8722;74-year-old patients, the ADR in men was significantly higher than that in women at every age interval (<italic toggle="yes">P</italic> &lt; .05). No difference was observed in ADR at other age intervals. In 45&#8722;69-year-old patients, the AADR in men was significantly higher than that of women at every age interval (<italic toggle="yes">P</italic> &lt; .05), with no difference at other age intervals (<xref rid="table4-10732748231193243" ref-type="table">Tables 4</xref> and <xref rid="table5-10732748231193243" ref-type="table">5</xref>).<table-wrap position="float" id="table4-10732748231193243" orientation="portrait"><label>Table 4.</label><caption><p>Comparison of ADR Between Male and Female in Different Age Groups.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="table4-10732748231193243" position="float" orientation="portrait" xlink:href="10.1177_10732748231193243-table4.jpg"/><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="2" colspan="1">Age/yr</th><th align="center" colspan="3" rowspan="1">Male</th><th align="center" colspan="3" rowspan="1">Female</th><th align="center" rowspan="2" colspan="1">
<italic toggle="yes">P</italic>
</th></tr><tr><th align="center" rowspan="1" colspan="1">N</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">ADR(%)</th><th align="center" rowspan="1" colspan="1">N</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">ADR(%)</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">&lt;34</td><td align="char" char="." rowspan="1" colspan="1">1155</td><td align="char" char="." rowspan="1" colspan="1">34</td><td align="char" char="." rowspan="1" colspan="1">2.94</td><td align="char" char="." rowspan="1" colspan="1">802</td><td align="char" char="." rowspan="1" colspan="1">17</td><td align="char" char="." rowspan="1" colspan="1">2.12</td><td align="char" char="." rowspan="1" colspan="1">.26</td></tr><tr><td align="left" rowspan="1" colspan="1">35&#8211;39</td><td align="char" char="." rowspan="1" colspan="1">848</td><td align="char" char="." rowspan="1" colspan="1">57</td><td align="char" char="." rowspan="1" colspan="1">6.72</td><td align="char" char="." rowspan="1" colspan="1">614</td><td align="char" char="." rowspan="1" colspan="1">25</td><td align="char" char="." rowspan="1" colspan="1">4.07</td><td align="char" char="." rowspan="1" colspan="1">.03</td></tr><tr><td align="left" rowspan="1" colspan="1">40&#8211;44</td><td align="char" char="." rowspan="1" colspan="1">914</td><td align="char" char="." rowspan="1" colspan="1">82</td><td align="char" char="." rowspan="1" colspan="1">8.97</td><td align="char" char="." rowspan="1" colspan="1">774</td><td align="char" char="." rowspan="1" colspan="1">47</td><td align="char" char="." rowspan="1" colspan="1">6.07</td><td align="char" char="." rowspan="1" colspan="1">.03</td></tr><tr><td align="left" rowspan="1" colspan="1">45&#8211;49</td><td align="char" char="." rowspan="1" colspan="1">1135</td><td align="char" char="." rowspan="1" colspan="1">170</td><td align="char" char="." rowspan="1" colspan="1">14.98</td><td align="char" char="." rowspan="1" colspan="1">1058</td><td align="char" char="." rowspan="1" colspan="1">66</td><td align="char" char="." rowspan="1" colspan="1">6.24</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">50&#8211;54</td><td align="char" char="." rowspan="1" colspan="1">1283</td><td align="char" char="." rowspan="1" colspan="1">256</td><td align="char" char="." rowspan="1" colspan="1">19.95</td><td align="char" char="." rowspan="1" colspan="1">1373</td><td align="char" char="." rowspan="1" colspan="1">151</td><td align="char" char="." rowspan="1" colspan="1">11.00</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">55&#8211;59</td><td align="char" char="." rowspan="1" colspan="1">1460</td><td align="char" char="." rowspan="1" colspan="1">369</td><td align="char" char="." rowspan="1" colspan="1">25.27</td><td align="char" char="." rowspan="1" colspan="1">1586</td><td align="char" char="." rowspan="1" colspan="1">242</td><td align="char" char="." rowspan="1" colspan="1">15.26</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">60&#8211;64</td><td align="char" char="." rowspan="1" colspan="1">950</td><td align="char" char="." rowspan="1" colspan="1">292</td><td align="char" char="." rowspan="1" colspan="1">30.74</td><td align="char" char="." rowspan="1" colspan="1">916</td><td align="char" char="." rowspan="1" colspan="1">167</td><td align="char" char="." rowspan="1" colspan="1">18.23</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">65&#8211;69</td><td align="char" char="." rowspan="1" colspan="1">1162</td><td align="char" char="." rowspan="1" colspan="1">363</td><td align="char" char="." rowspan="1" colspan="1">31.24</td><td align="char" char="." rowspan="1" colspan="1">891</td><td align="char" char="." rowspan="1" colspan="1">192</td><td align="char" char="." rowspan="1" colspan="1">21.55</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">70&#8211;74</td><td align="char" char="." rowspan="1" colspan="1">823</td><td align="char" char="." rowspan="1" colspan="1">302</td><td align="char" char="." rowspan="1" colspan="1">36.70</td><td align="char" char="." rowspan="1" colspan="1">587</td><td align="char" char="." rowspan="1" colspan="1">166</td><td align="char" char="." rowspan="1" colspan="1">28.28</td><td align="char" char="." rowspan="1" colspan="1">.001</td></tr><tr><td align="left" rowspan="1" colspan="1">75&#8211;79</td><td align="char" char="." rowspan="1" colspan="1">301</td><td align="char" char="." rowspan="1" colspan="1">124</td><td align="char" char="." rowspan="1" colspan="1">41.20</td><td align="char" char="." rowspan="1" colspan="1">155</td><td align="char" char="." rowspan="1" colspan="1">60</td><td align="char" char="." rowspan="1" colspan="1">38.71</td><td align="char" char="." rowspan="1" colspan="1">.61</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8805;80</td><td align="char" char="." rowspan="1" colspan="1">112</td><td align="char" char="." rowspan="1" colspan="1">40</td><td align="char" char="." rowspan="1" colspan="1">35.71</td><td align="char" char="." rowspan="1" colspan="1">29</td><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">34.48</td><td align="char" char="." rowspan="1" colspan="1">.90</td></tr></tbody></table></alternatives></table-wrap><table-wrap position="float" id="table5-10732748231193243" orientation="portrait"><label>Table 5.</label><caption><p>Comparison of AADR Between Male and Female in Different age Groups.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="table5-10732748231193243" position="float" orientation="portrait" xlink:href="10.1177_10732748231193243-table5.jpg"/><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="2" colspan="1">Age/yr</th><th align="center" colspan="3" rowspan="1">Male</th><th align="center" colspan="3" rowspan="1">Female</th><th align="center" rowspan="2" colspan="1">
<italic toggle="yes">P</italic>
</th></tr><tr><th align="center" rowspan="1" colspan="1">N</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">AADR(%)</th><th align="center" rowspan="1" colspan="1">N</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">AADR(%)</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">&lt;34</td><td align="char" char="." rowspan="1" colspan="1">1155</td><td align="char" char="." rowspan="1" colspan="1">6</td><td align="char" char="." rowspan="1" colspan="1">.52</td><td align="char" char="." rowspan="1" colspan="1">802</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">.37</td><td align="char" char="." rowspan="1" colspan="1">.64</td></tr><tr><td align="left" rowspan="1" colspan="1">35&#8211;39</td><td align="char" char="." rowspan="1" colspan="1">848</td><td align="char" char="." rowspan="1" colspan="1">11</td><td align="char" char="." rowspan="1" colspan="1">1.30</td><td align="char" char="." rowspan="1" colspan="1">614</td><td align="char" char="." rowspan="1" colspan="1">7</td><td align="char" char="." rowspan="1" colspan="1">1.14</td><td align="char" char="." rowspan="1" colspan="1">.79</td></tr><tr><td align="left" rowspan="1" colspan="1">40&#8211;44</td><td align="char" char="." rowspan="1" colspan="1">914</td><td align="char" char="." rowspan="1" colspan="1">20</td><td align="char" char="." rowspan="1" colspan="1">2.19</td><td align="char" char="." rowspan="1" colspan="1">774</td><td align="char" char="." rowspan="1" colspan="1">11</td><td align="char" char="." rowspan="1" colspan="1">1.42</td><td align="char" char="." rowspan="1" colspan="1">.24</td></tr><tr><td align="left" rowspan="1" colspan="1">45&#8211;49</td><td align="char" char="." rowspan="1" colspan="1">1135</td><td align="char" char="." rowspan="1" colspan="1">54</td><td align="char" char="." rowspan="1" colspan="1">4.76</td><td align="char" char="." rowspan="1" colspan="1">1058</td><td align="char" char="." rowspan="1" colspan="1">20</td><td align="char" char="." rowspan="1" colspan="1">1.89</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">50&#8211;54</td><td align="char" char="." rowspan="1" colspan="1">1283</td><td align="char" char="." rowspan="1" colspan="1">78</td><td align="char" char="." rowspan="1" colspan="1">6.08</td><td align="char" char="." rowspan="1" colspan="1">1373</td><td align="char" char="." rowspan="1" colspan="1">43</td><td align="char" char="." rowspan="1" colspan="1">3.13</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">55&#8211;59</td><td align="char" char="." rowspan="1" colspan="1">1460</td><td align="char" char="." rowspan="1" colspan="1">108</td><td align="char" char="." rowspan="1" colspan="1">7.40</td><td align="char" char="." rowspan="1" colspan="1">1586</td><td align="char" char="." rowspan="1" colspan="1">66</td><td align="char" char="." rowspan="1" colspan="1">4.16</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">60&#8211;64</td><td align="char" char="." rowspan="1" colspan="1">950</td><td align="char" char="." rowspan="1" colspan="1">89</td><td align="char" char="." rowspan="1" colspan="1">9.37</td><td align="char" char="." rowspan="1" colspan="1">916</td><td align="char" char="." rowspan="1" colspan="1">43</td><td align="char" char="." rowspan="1" colspan="1">4.69</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">65&#8211;69</td><td align="char" char="." rowspan="1" colspan="1">1162</td><td align="char" char="." rowspan="1" colspan="1">136</td><td align="char" char="." rowspan="1" colspan="1">11.70</td><td align="char" char="." rowspan="1" colspan="1">891</td><td align="char" char="." rowspan="1" colspan="1">51</td><td align="char" char="." rowspan="1" colspan="1">5.72</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">70&#8211;74</td><td align="char" char="." rowspan="1" colspan="1">823</td><td align="char" char="." rowspan="1" colspan="1">105</td><td align="char" char="." rowspan="1" colspan="1">12.76</td><td align="char" char="." rowspan="1" colspan="1">587</td><td align="char" char="." rowspan="1" colspan="1">62</td><td align="char" char="." rowspan="1" colspan="1">10.56</td><td align="char" char="." rowspan="1" colspan="1">.208</td></tr><tr><td align="left" rowspan="1" colspan="1">75&#8211;79</td><td align="char" char="." rowspan="1" colspan="1">301</td><td align="char" char="." rowspan="1" colspan="1">41</td><td align="char" char="." rowspan="1" colspan="1">13.62</td><td align="char" char="." rowspan="1" colspan="1">155</td><td align="char" char="." rowspan="1" colspan="1">19</td><td align="char" char="." rowspan="1" colspan="1">12.26</td><td align="char" char="." rowspan="1" colspan="1">.68</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8805;80</td><td align="char" char="." rowspan="1" colspan="1">112</td><td align="char" char="." rowspan="1" colspan="1">15</td><td align="char" char="." rowspan="1" colspan="1">13.39</td><td align="char" char="." rowspan="1" colspan="1">29</td><td align="char" char="." rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">13.79</td><td align="char" char="." rowspan="1" colspan="1">.96</td></tr></tbody></table></alternatives></table-wrap></p></sec><sec id="sec15-10732748231193243"><title>Results According to Polyp Histopathology</title><p>Among the 4774 polyps, 2884 tubular adenomas, 302 tubular-villous adenomas, and 46 villous adenomas were identified, accounting for 60.41%, 6.33%, and .96%, respectively. Tubular adenomas, tubular-villous adenomas, and villous adenomas accounted for 89.23%, 9.34%, and 1.42% of colorectal adenomas, respectively. Serrated adenomas and hyperplastic polyps were detected in 80 and 452 patients, accounting for 1.68% and 9.47% of the polyps, respectively. SSLs accounted for 11.15% of the polyps. Inflammatory polyps were detected in 994 patients, accounting for 20.82% of all polyps. Adenocarcinoma was detected in four patients (.08%). Other cases included three cases of neuroendocrine tumors, eight cases of juvenile polyps, and one case of leiomyoma. No significant difference was observed in the men-to-women ratio among the various pathological types (<italic toggle="yes">P</italic> = .60). The number of patients with tubular, tubulovillous, and villous adenomas progressively increased with age, with a statistically significant difference (<italic toggle="yes">P</italic> &lt; .05). The size of the tubular, tubulovillous, and villous adenomas gradually increased, with a statistically significant difference (<italic toggle="yes">P</italic> &lt; .05) (<xref rid="table6-10732748231193243" ref-type="table">Table 6</xref>).<table-wrap position="float" id="table6-10732748231193243" orientation="portrait"><label>Table 6.</label><caption><p>Characteristics of Different Pathological Types of Polyps.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="table6-10732748231193243" position="float" orientation="portrait" xlink:href="10.1177_10732748231193243-table6.jpg"/><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">Histological type</th><th align="center" rowspan="1" colspan="1">N (%)</th><th align="center" rowspan="1" colspan="1">Median age(range, IQR), yr</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th><th align="center" rowspan="1" colspan="1">Median size (range, IQR), cm</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th><th align="center" rowspan="1" colspan="1">Male/Female(n)</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Inflammatory polyps</td><td align="char" char="(" rowspan="1" colspan="1">994(20.82)</td><td align="char" char="(" rowspan="1" colspan="1">53(22-85, 18)</td><td align="center" rowspan="1" colspan="1">/</td><td align="char" char="(" rowspan="1" colspan="1">.5(.2-1.8,0.3)</td><td align="center" rowspan="1" colspan="1">/</td><td align="center" rowspan="1" colspan="1">627/367</td><td align="char" char="." rowspan="8" colspan="1">.60</td></tr><tr><td align="left" rowspan="1" colspan="1">Hyperplastic polyps</td><td align="char" char="(" rowspan="1" colspan="1">452(9.47)</td><td align="char" char="(" rowspan="1" colspan="1">55(23-84, 18)</td><td align="left" rowspan="1" colspan="1">.01</td><td align="char" char="(" rowspan="1" colspan="1">.5(.2-1.5,0.2)</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td><td align="center" rowspan="1" colspan="1">301/151</td></tr><tr><td align="left" rowspan="1" colspan="1">Serrated adenomas</td><td align="char" char="(" rowspan="1" colspan="1">80(1.68)</td><td align="char" char="(" rowspan="1" colspan="1">57(32-80, 16.5)</td><td align="left" rowspan="1" colspan="1">.01</td><td align="char" char="(" rowspan="1" colspan="1">.8(.3-3.5,0.48)</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td><td align="center" rowspan="1" colspan="1">54/26</td></tr><tr><td align="left" rowspan="1" colspan="1">Tubular adenoma</td><td align="char" char="(" rowspan="1" colspan="1">2884(60.41)</td><td align="char" char="(" rowspan="1" colspan="1">60(23-90, 15)</td><td align="left" rowspan="1" colspan="1">.26</td><td align="char" char="(" rowspan="1" colspan="1">.6(.2-4.0, .3)</td><td align="char" char="." rowspan="1" colspan="1">.09</td><td align="center" rowspan="1" colspan="1">1873/1011</td></tr><tr><td align="left" rowspan="1" colspan="1">Tubular-villous adenoma</td><td align="char" char="(" rowspan="1" colspan="1">302(6.33)</td><td align="char" char="(" rowspan="1" colspan="1">64(30-84, 13)</td><td align="left" rowspan="1" colspan="1">&lt;.001</td><td align="char" char="(" rowspan="1" colspan="1">1.2(.4-6.0, .7)</td><td align="char" char="." rowspan="1" colspan="1">&lt;.001</td><td align="center" rowspan="1" colspan="1">191/111</td></tr><tr><td align="left" rowspan="1" colspan="1">Villous adenoma</td><td align="char" char="(" rowspan="1" colspan="1">46(.96)</td><td align="char" char="(" rowspan="1" colspan="1">68.5(42-84, 14.5)</td><td align="left" rowspan="1" colspan="1">.004</td><td align="char" char="(" rowspan="1" colspan="1">1.5(.5-5.0, 1.13)</td><td align="char" char="." rowspan="1" colspan="1">.004</td><td align="center" rowspan="1" colspan="1">25/21</td></tr><tr><td align="left" rowspan="1" colspan="1">Adenocarcinoma</td><td align="char" char="(" rowspan="1" colspan="1">4(.08)</td><td align="char" char="(" rowspan="1" colspan="1">66.5(54-75,16.5)</td><td align="center" rowspan="1" colspan="1">/</td><td align="char" char="(" rowspan="1" colspan="1">1.1(1.0-2.0,0.8)</td><td align="center" rowspan="1" colspan="1">/</td><td align="center" rowspan="1" colspan="1">3/1</td></tr><tr><td align="left" rowspan="1" colspan="1">Others</td><td align="char" char="(" rowspan="1" colspan="1">12(.27)</td><td align="char" char="(" rowspan="1" colspan="1">50.5(29-75, 19.5)</td><td align="center" rowspan="1" colspan="1">/</td><td align="char" char="(" rowspan="1" colspan="1">1.0(.5-3.0,1.35)</td><td align="center" rowspan="1" colspan="1">/</td><td align="center" rowspan="1" colspan="1">8/4</td></tr></tbody></table></alternatives></table-wrap></p></sec></sec><sec sec-type="discussion" id="sec16-10732748231193243"><title>Discussion</title><p>Our study demonstrated that both the ADR and AADR increase with age in an average-risk population and their growth rate starts to increase in individuals aged 45&#160;years and older, especially in men. Karsenti D et al<sup>
<xref rid="bibr8-10732748231193243" ref-type="bibr">8</xref>
</sup> also showed that ADR started to increase from 45&#160;years of age, but this study only explored the change rule of ADR in the entire population and did not conduct a comparative study between the rates in men and women. We found that the ADR of male patients aged 45&#8722;49 was significantly higher than that of female patients, with a 2.4-fold increase, whereas this gap was not as large at other age intervals. The AADR showed a similar trend. The essential reason for this phenomenon is that ADR and AADR start to increase markedly from the age of 45&#160;years in men, while they start to increase markedly from the age of 50&#160;years in women. Coincidentally, the average age of menopause in women is approximately 50&#160;years.<sup>
<xref rid="bibr15-10732748231193243" ref-type="bibr">15</xref>
</sup> This coincidence led us to consider whether menopause increases the incidence of colorectal adenomas. Although previous studies<sup><xref rid="bibr16-10732748231193243" ref-type="bibr">16</xref>,<xref rid="bibr17-10732748231193243" ref-type="bibr">17</xref></sup> have confirmed that postmenopausal estrogen and progesterone replacement therapy can reduce the risk of CRC, whether menopause increases the incidence of colorectal adenomas remains unclear. Although many previous studies have confirmed that the male sex is associated with higher ADR,<sup><xref rid="bibr18-10732748231193243" ref-type="bibr">18</xref>-<xref rid="bibr20-10732748231193243" ref-type="bibr">20</xref></sup> to the best of our knowledge, our study is the first to find that ADR increases markedly at an earlier age of approximately 5&#160;years in average-risk of men compared to women. We also found the same trend in AADR, although it was not statistically significant. The National Cancer Center of China recommends that colonoscopy screening starts at the age of 40&#160;years in a high-risk population or 10&#160;years earlier than in the youngest person with CRC in a first-degree relative.<sup>
<xref rid="bibr7-10732748231193243" ref-type="bibr">7</xref>
</sup> However, the age at which average-risk individuals begin colonoscopic screening has not yet been determined. Consistent with the existing literature,<sup>
<xref rid="bibr8-10732748231193243" ref-type="bibr">8</xref>
</sup> our study provides strong evidence for the initiation of colonoscopy screening at 45&#160;years of age in an average-risk population, especially in men.</p><p>Many quality indicators have been proposed for colonoscopy; however, ADR and cecal intubation rate are the most commonly used and recognized.<sup><xref rid="bibr21-10732748231193243" ref-type="bibr">21</xref>,<xref rid="bibr22-10732748231193243" ref-type="bibr">22</xref></sup> ADR has been validated as predictors of cancer occurring after colonoscopy.<sup>
<xref rid="bibr23-10732748231193243" ref-type="bibr">23</xref>
</sup> The currently recommended minimal thresholds for detection are &#8805;25% overall or should be &#8805; 30% for male patients and should be &#8805; 20% for female patients.<sup>
<xref rid="bibr5-10732748231193243" ref-type="bibr">5</xref>
</sup> In our study, the overall ADR was 17.08% (20.60% in men, 13.01% in women). This lower ADR than the recommended value could be due to the following reasons: First, all included patients were at average risk for CRC. Previous studies have shown that high-risk populations of CRC may have higher ADR.<sup><xref rid="bibr8-10732748231193243" ref-type="bibr">8</xref>,<xref rid="bibr24-10732748231193243" ref-type="bibr">24</xref></sup> Secondly, half of the patients included aged &#8804;54&#160;years, in particular, more than half of the women were &#8804;54&#160;years. Previous studies have shown that ADRs are strongly age-related and continue to increase with increasing age.<sup><xref rid="bibr24-10732748231193243" ref-type="bibr">24</xref>,<xref rid="bibr25-10732748231193243" ref-type="bibr">25</xref></sup> Third, the incidence and prevalence of colorectal cancer in China are lower than those in the United States.<sup>
<xref rid="bibr10-10732748231193243" ref-type="bibr">10</xref>
</sup> However, these standards are based on the recommendations of the US MSTF on colorectal cancer.<sup>
<xref rid="bibr5-10732748231193243" ref-type="bibr">5</xref>
</sup> More research on CRC is needed to develop standards suitable for China, especially for young average-risk populations. Fourth, most patients included in our study resided in rural areas of China and had a lower rate of CRC.<sup>
<xref rid="bibr11-10732748231193243" ref-type="bibr">11</xref>
</sup></p><p>In this study, we found that advanced adenomas were significantly larger than non-advanced adenomas, and patients with advanced adenomas were significantly older than those with non-advanced adenomas. The proportion of villous components in adenomas positively correlated with patient age and adenoma size. This suggests that cancer risk in patients with colorectal adenoma is positively correlated with age and adenoma size. These findings are similar to those of previously published data.<sup><xref rid="bibr26-10732748231193243" ref-type="bibr">26</xref>,<xref rid="bibr27-10732748231193243" ref-type="bibr">27</xref></sup> Our study showed that tubular adenoma was the most common pathological type of colorectal polyp, followed by an inflammatory polyp, hyperplastic polyp, and tubular-villous adenoma. These results are similar to those of previous studies.<sup><xref rid="bibr28-10732748231193243" ref-type="bibr">28</xref>,<xref rid="bibr29-10732748231193243" ref-type="bibr">29</xref></sup> Other pathological types, such as villous adenomas, serrated adenomas, juvenile polyps, and adenocarcinomas, are relatively rare. To some extent, our clinical research data reflect the characteristics of the pathological composition of polyps in this region in the average-risk population of CRC.</p><p>Serrated adenomas, including sessile serrated adenomas (also known as sessile serrated polyps) and traditional serrated adenomas, have emerged as important lesions in colorectal carcinogenesis through the serrated polyp neoplasia pathway and have been recognized as precursor lesions of interval cancer.<sup>
<xref rid="bibr30-10732748231193243" ref-type="bibr">30</xref>
</sup> The proportion of serrated adenomas was lower than that in other published data (found in 8%&#8211;9% of screening colonoscopies performed by expert detectors).<sup><xref rid="bibr31-10732748231193243" ref-type="bibr">31</xref>,<xref rid="bibr32-10732748231193243" ref-type="bibr">32</xref></sup> This may be because the histological classification of serrated lesions varies widely among pathologists, and some serrated adenomas are judged as hyperplastic polyps or conventional adenomas. Previous reports also found a poor interobserver agreement between pathologists in the differentiation of hyperplastic polyps from sessile serrated polyps and tubular-villous adenomas from traditional serrated adenomas.<sup><xref rid="bibr30-10732748231193243" ref-type="bibr">30</xref>,<xref rid="bibr33-10732748231193243" ref-type="bibr">33</xref>,<xref rid="bibr34-10732748231193243" ref-type="bibr">34</xref></sup> More educational training among endoscopists and pathologists is essential for identifying serrated lesions.</p><p>Our study has some limitations. First, this was not a multicenter study and a limited number of patients were included. Therefore, the results of this study are not representative of the entire East China region. Second, this was a retrospective study, and information on smoking status, body mass index, medication use, and dietary habits were lacking. Bowel preparation quality and withdrawal time could not be controlled. These factors may have biased our results. Therefore, a prospective multicenter cohort study to remove these factors and obtain reliable results will be conducted.</p></sec><sec sec-type="conclusions" id="sec17-10732748231193243"><title>Conclusions</title><p>In conclusion, our study confirmed that the ADR and AADR increased significantly in whole average-risk population from 45&#160;years of age, and is the first to show that the ADR increased significantly in average-risk men aged 45&#160;years and older, 5&#160;years earlier than in women. This suggests that colonoscopy screening may begin at 45&#160;years of age in the average-risk population for CRC, especially in men.</p></sec><sec sec-type="supplementary-material" id="sec18-10732748231193243" specific-use="figshare"><title>Supplemental Material</title><supplementary-material id="suppl1-10732748231193243" position="float" content-type="local-data" orientation="portrait"><caption><title>Supplemental Material - Adenoma Detection Rate in Average-Risk Population: An Observational Consecutive Retrospective Study</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="sj-pdf-1-ccx-10.1177_10732748231193243.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media><p>Supplemental Material for Adenoma Detection Rate in Average-Risk Population: An Observational Consecutive Retrospective Study by Xiaoyan He, Xiangyin Lv, Binbin Zhang, Xiaoxuan Ying, Chiyu Hu, Xiaoying Zhou and Jianwen Hu in Cancer Control</p></supplementary-material></sec></body><back><ack><title>Acknowledgments</title><p>We would like to thank Editage (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.editage.com" ext-link-type="uri">www.editage.com</ext-link>) for English language editing.</p></ack><fn-group><fn fn-type="COI-statement"><p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> *The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the grants from the National Natural Science Foundation of China (82100594) and the medical and health research project of Zhejiang province (2022KY429).</p></fn><fn fn-type="other"><p><bold>Ethical Approval:</bold> The study was approved by the Medical Ethics Committee of Dongyang People's Hospital, under number DRY 2021-YX-240.</p></fn><fn fn-type="other"><p><bold>Informed Consent:</bold> Informed consent was obtained from all subjects or their legal guardians. All methods were carried out in accordance with relevant guidelines and regulations.</p></fn></fn-group><fn-group><fn fn-type="supplementary-material"><p><bold>Supplemental Material:</bold> Supplemental material for this article is available online.</p></fn></fn-group><sec id="sec23-10732748231193243"><title>ORCID iDs</title><p>Xiaoyan He <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0003-4760-1789" ext-link-type="uri">https://orcid.org/0000-0003-4760-1789</ext-link></p><p>Xiangyin Lv <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0009-0005-8207-4912" ext-link-type="uri">https://orcid.org/0009-0005-8207-4912</ext-link></p><p>Binbin Zhang <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0009-0006-9783-6120" ext-link-type="uri">https://orcid.org/0009-0006-9783-6120</ext-link></p><p>Xiaoxuan Ying <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0009-0004-4177-6267" ext-link-type="uri">https://orcid.org/0009-0004-4177-6267</ext-link></p><p>Chiyu Hu <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0009-0001-6858-5450" ext-link-type="uri">https://orcid.org/0009-0001-6858-5450</ext-link></p><p>Xiaoying Zhou <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0002-6529-0243" ext-link-type="uri">https://orcid.org/0000-0002-6529-0243</ext-link></p><p>Jianwen Hu <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0002-1239-7151" ext-link-type="uri">https://orcid.org/0000-0002-1239-7151</ext-link></p></sec><ref-list><title>References</title><ref id="bibr1-10732748231193243"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmed</surname><given-names>M</given-names></name></person-group>. <article-title>Colon cancer: a clinician's perspective in 2019</article-title>. <source>Gastroenterology Res</source>. <year>2020</year>;<volume>13</volume>(<issue>1</issue>):<fpage>1</fpage>-<lpage>10</lpage>.<pub-id pub-id-type="pmid">32095167</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.14740/gr1239</pub-id><pub-id pub-id-type="pmcid">PMC7011914</pub-id></mixed-citation></ref><ref id="bibr2-10732748231193243"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name><name name-style="western"><surname>Miller</surname><given-names>KD</given-names></name><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name></person-group>. <article-title>Cancer statistics</article-title>. <source>CA Cancer J Clin</source>. <year>2019</year>;<volume>69</volume>(<issue>1</issue>):<fpage>7</fpage>-<lpage>34</lpage>.<pub-id pub-id-type="pmid">30620402</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.21551</pub-id></mixed-citation></ref><ref id="bibr3-10732748231193243"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brenner</surname><given-names>H</given-names></name><name name-style="western"><surname>Hoffmeister</surname><given-names>M</given-names></name><name name-style="western"><surname>Stegmaier</surname><given-names>C</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>G</given-names></name><name name-style="western"><surname>Altenhofen</surname><given-names>L</given-names></name><name name-style="western"><surname>Haug</surname><given-names>U</given-names></name></person-group>. <article-title>Risk of progression of advanced adenomas to colorectal cancer by age and sex: Estimates based on 840,149 screening colonoscopies</article-title>. <source>Gut</source>. <year>2007</year>;<volume>56</volume>(<issue>11</issue>):<fpage>1585</fpage>-<lpage>1589</lpage>.<pub-id pub-id-type="pmid">17591622</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gut.2007.122739</pub-id><pub-id pub-id-type="pmcid">PMC2095643</pub-id></mixed-citation></ref><ref id="bibr4-10732748231193243"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freitas</surname><given-names>JA</given-names></name><name name-style="western"><surname>Gullo</surname><given-names>I</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>D</given-names></name></person-group>. <article-title>The adaptive immune landscape of the colorectal adenoma-carcinoma sequence</article-title>. <source>Int J Mol Sci</source>. <year>2021</year>;<volume>18</volume>:<fpage>22</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22189791</pub-id><pub-id pub-id-type="pmcid">PMC8472388</pub-id><pub-id pub-id-type="pmid">34575971</pub-id></mixed-citation></ref><ref id="bibr5-10732748231193243"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rex</surname><given-names>DK</given-names></name><name name-style="western"><surname>Boland</surname><given-names>CR</given-names></name><name name-style="western"><surname>Dominitz</surname><given-names>JA</given-names></name></person-group>. <article-title>Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-society Task Force on colorectal cancer</article-title>. <source>Gastrointest Endosc</source>. <year>2017</year>;<volume>86</volume>(<issue>1</issue>):<fpage>18</fpage>-<lpage>33</lpage>.<pub-id pub-id-type="pmid">28600070</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.gie.2017.04.003</pub-id></mixed-citation></ref><ref id="bibr6-10732748231193243"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zauber</surname><given-names>AG</given-names></name><name name-style="western"><surname>Winawer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>O'Brien</surname><given-names>MJ</given-names></name></person-group>. <article-title>Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths</article-title>. <source>N Engl J Med</source>. <year>2012</year>;<volume>366</volume>(<issue>8</issue>):<fpage>687</fpage>-<lpage>696</lpage>.<pub-id pub-id-type="pmid">22356322</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1100370</pub-id><pub-id pub-id-type="pmcid">PMC3322371</pub-id></mixed-citation></ref><ref id="bibr7-10732748231193243"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>National Cancer Center CEGotDoCGftSED, Early Treatment of Colorectal C</collab></person-group>. <article-title>[China guideline for the screening, early detection and early treatment of colorectal cancer (2020, Beijing)]</article-title>. <source>Zhonghua Zhong Liu Za Zhi</source>. <year>2021</year>;<volume>43</volume>(<issue>1</issue>):<fpage>16</fpage>-<lpage>38</lpage>.<pub-id pub-id-type="pmid">33472315</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3760/cma.j.cn112152-20210105-00010</pub-id></mixed-citation></ref><ref id="bibr8-10732748231193243"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karsenti</surname><given-names>D</given-names></name><name name-style="western"><surname>Tharsis</surname><given-names>G</given-names></name><name name-style="western"><surname>Burtin</surname><given-names>P</given-names></name></person-group>. <article-title>Adenoma and advanced neoplasia detection rates increase from 45&#160;years of age</article-title>. <source>World J Gastroenterol</source>. <year>2019</year>;<volume>25</volume>(<issue>4</issue>):<fpage>447</fpage>-<lpage>456</lpage>.<pub-id pub-id-type="pmid">30700941</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3748/wjg.v25.i4.447</pub-id><pub-id pub-id-type="pmcid">PMC6350166</pub-id></mixed-citation></ref><ref id="bibr9-10732748231193243"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winkels</surname><given-names>RM</given-names></name><name name-style="western"><surname>Kampman</surname><given-names>E</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name></person-group>. <article-title>Learning from East to West and vice versa: clinical epidemiology of colorectal cancer in China</article-title>. <source>Cancer</source>. <year>2021</year>;<volume>127</volume>(<issue>11</issue>):<fpage>1736</fpage>-<lpage>1738</lpage>.<pub-id pub-id-type="pmid">33788256</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.33444</pub-id></mixed-citation></ref><ref id="bibr10-10732748231193243"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L</given-names></name><name name-style="western"><surname>He</surname><given-names>X</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name></person-group>. <article-title>Gastrointestinal cancers in China, the USA, and Europe</article-title>. <source>Gastroenterol Rep (Oxf)</source>. <year>2021</year>;<volume>9</volume>(<issue>2</issue>):<fpage>91</fpage>-<lpage>104</lpage>.<pub-id pub-id-type="pmid">34026216</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/gastro/goab010</pub-id><pub-id pub-id-type="pmcid">PMC8128023</pub-id></mixed-citation></ref><ref id="bibr11-10732748231193243"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>S</given-names></name><name name-style="western"><surname>Xie</surname><given-names>SH</given-names></name></person-group>. <article-title>Urban-rural disparity in cancer incidence in China, 2008-2012: a cross-sectional analysis of data from 36 cancer registers</article-title>. <source>BMJ Open</source>. <year>2021</year>;<volume>11</volume>(<issue>4</issue>):<fpage>e042762</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2020-042762</pub-id><pub-id pub-id-type="pmcid">PMC8098914</pub-id><pub-id pub-id-type="pmid">33931407</pub-id></mixed-citation></ref><ref id="bibr12-10732748231193243"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Elm</surname><given-names>E</given-names></name><name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name></person-group>. <article-title>The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies</article-title>. <source>Ann Intern Med</source>. <year>2007</year>;<volume>147</volume>(<issue>8</issue>):<fpage>573</fpage>-<lpage>577</lpage>.<pub-id pub-id-type="pmid">17938396</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/0003-4819-147-8-200710160-00010</pub-id></mixed-citation></ref><ref id="bibr13-10732748231193243"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>S</given-names></name><name name-style="western"><surname>Lieberman</surname><given-names>D</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>JC</given-names></name></person-group>. <article-title>Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US multi-society task force on colorectal cancer</article-title>. <source>Gastroenterology</source>. <year>2020</year>;<volume>158</volume>(<issue>4</issue>):<fpage>1131</fpage>-<lpage>1153</lpage>. <comment>e5</comment>.<pub-id pub-id-type="pmid">32044092</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2019.10.026</pub-id><pub-id pub-id-type="pmcid">PMC7672705</pub-id></mixed-citation></ref><ref id="bibr14-10732748231193243"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>B</given-names></name><name name-style="western"><surname>Kochhar</surname><given-names>GS</given-names></name><name name-style="western"><surname>Rubin</surname><given-names>DT</given-names></name></person-group>. <article-title>Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International ileal pouch consortium</article-title>. <source>Lancet Gastroenterol Hepatol</source>. <year>2022</year>;<volume>7</volume>(<issue>1</issue>):<fpage>69</fpage>-<lpage>95</lpage>.<pub-id pub-id-type="pmid">34774224</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2468-1253(21)00214-4</pub-id></mixed-citation></ref><ref id="bibr15-10732748231193243"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baber</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Panay</surname><given-names>N</given-names></name><name name-style="western"><surname>Fenton</surname><given-names>A</given-names></name><name name-style="western"><surname>Group</surname><given-names>IMSW</given-names></name></person-group>. <year>2016</year><article-title>IMS recommendations on women's midlife health and menopause hormone therapy</article-title>. <source>Climacteric</source><year>2016</year>;<volume>19</volume>(<issue>2</issue>):<fpage>109</fpage>-<lpage>150</lpage>.<pub-id pub-id-type="pmid">26872610</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/13697137.2015.1129166</pub-id></mixed-citation></ref><ref id="bibr16-10732748231193243"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manson</surname><given-names>JE</given-names></name><name name-style="western"><surname>Chlebowski</surname><given-names>RT</given-names></name><name name-style="western"><surname>Stefanick</surname><given-names>ML</given-names></name></person-group>. <article-title>Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials</article-title>. <source>JAMA</source>. <year>2013</year>;<volume>310</volume>(<issue>13</issue>):<fpage>1353</fpage>-<lpage>1368</lpage>.<pub-id pub-id-type="pmid">24084921</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2013.278040</pub-id><pub-id pub-id-type="pmcid">PMC3963523</pub-id></mixed-citation></ref><ref id="bibr17-10732748231193243"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stuenkel</surname><given-names>CA</given-names></name><name name-style="western"><surname>Davis</surname><given-names>SR</given-names></name><name name-style="western"><surname>Gompel</surname><given-names>A</given-names></name></person-group>. <article-title>Treatment of symptoms of the menopause: an endocrine society clinical practice guideline</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2015</year>;<volume>100</volume>(<issue>11</issue>):<fpage>3975</fpage>-<lpage>4011</lpage>.<pub-id pub-id-type="pmid">26444994</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1210/jc.2015-2236</pub-id></mixed-citation></ref><ref id="bibr18-10732748231193243"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vojtechova</surname><given-names>G</given-names></name><name name-style="western"><surname>Ngo</surname><given-names>O</given-names></name><name name-style="western"><surname>Grega</surname><given-names>T</given-names></name></person-group>. <article-title>The conversion factor for predicting adenoma detection rate from polyp detection rate varies according to colonoscopy indication and patient sex</article-title>. <source>Eur J Cancer Prev</source>. <year>2020</year>;<volume>29</volume>(<issue>4</issue>):<fpage>294</fpage>-<lpage>302</lpage>.<pub-id pub-id-type="pmid">32543806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/CEJ.0000000000000558</pub-id></mixed-citation></ref><ref id="bibr19-10732748231193243"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halfter</surname><given-names>K</given-names></name><name name-style="western"><surname>Bauerfeind</surname><given-names>L</given-names></name><name name-style="western"><surname>Schlesinger-Raab</surname><given-names>A</given-names></name></person-group>. <article-title>Colonoscopy and polypectomy: beside age, size of polyps main factor for long-term risk of colorectal cancer in a screening population</article-title>. <source>J Cancer Res Clin Oncol</source>. <year>2021</year>;<volume>147</volume>(<issue>9</issue>):<fpage>2645</fpage>-<lpage>2658</lpage>.<pub-id pub-id-type="pmid">33543329</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00432-021-03532-7</pub-id><pub-id pub-id-type="pmcid">PMC8310861</pub-id></mixed-citation></ref><ref id="bibr20-10732748231193243"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cavicchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Tharsis</surname><given-names>G</given-names></name><name name-style="western"><surname>Burtin</surname><given-names>P</given-names></name></person-group>. <article-title>Difference in physician- and patient-dependent factors contributing to adenoma detection rate and serrated polyp detection rate</article-title>. <source>Dig Dis Sci</source>. <year>2019</year>;<volume>64</volume>(<issue>12</issue>):<fpage>3579</fpage>-<lpage>3588</lpage>.<pub-id pub-id-type="pmid">31471862</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10620-019-05808-y</pub-id></mixed-citation></ref><ref id="bibr21-10732748231193243"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rex</surname><given-names>DK</given-names></name><name name-style="western"><surname>Schoenfeld</surname><given-names>PS</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>J</given-names></name></person-group>. <article-title>Quality indicators for colonoscopy</article-title>. <source>Gastrointest Endosc</source>. <year>2015</year>;<volume>81</volume>(<issue>1</issue>):<fpage>31</fpage>-<lpage>53</lpage>.<pub-id pub-id-type="pmid">25480100</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.gie.2014.07.058</pub-id></mixed-citation></ref><ref id="bibr22-10732748231193243"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rex</surname><given-names>DK</given-names></name></person-group>. <article-title>Key quality indicators in colonoscopy</article-title>. <source>Gastroenterol Rep (Oxf)</source>. <year>2023</year>;<volume>11</volume>:<fpage>goad009</fpage>.<pub-id pub-id-type="pmid">36911141</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/gastro/goad009</pub-id><pub-id pub-id-type="pmcid">PMC10005623</pub-id></mixed-citation></ref><ref id="bibr23-10732748231193243"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brunner</surname><given-names>KT</given-names></name><name name-style="western"><surname>Calderwood</surname><given-names>AH</given-names></name></person-group>. <article-title>Quality in colonoscopy</article-title>. <source>Curr Gastroenterol Rep</source>. <year>2015</year>;<volume>17</volume>(<issue>10</issue>):<fpage>461</fpage>.<pub-id pub-id-type="pmid">26292664</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11894-015-0461-1</pub-id></mixed-citation></ref><ref id="bibr24-10732748231193243"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>MH</given-names></name><name name-style="western"><surname>Rampal</surname><given-names>S</given-names></name><name name-style="western"><surname>Sung</surname><given-names>J</given-names></name></person-group>. <article-title>The prevalence of colorectal adenomas in asymptomatic Korean men and women</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2014</year>;<volume>23</volume>(<issue>3</issue>):<fpage>499</fpage>-<lpage>507</lpage>.<pub-id pub-id-type="pmid">24443404</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1055-9965.EPI-13-0682</pub-id></mixed-citation></ref><ref id="bibr25-10732748231193243"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bae</surname><given-names>T</given-names></name><name name-style="western"><surname>Ha</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kim</surname><given-names>C</given-names></name></person-group>. <article-title>Distribution of the colonoscopic adenoma detection rate according to age: is recommending colonoscopy screening for Koreans over the age of 50 safe?</article-title><source>Ann Coloproctol</source>. <year>2015</year>;<volume>31</volume>(<issue>2</issue>):<fpage>46</fpage>-<lpage>51</lpage>.<pub-id pub-id-type="pmid">25960971</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3393/ac.2015.31.2.46</pub-id><pub-id pub-id-type="pmcid">PMC4422986</pub-id></mixed-citation></ref><ref id="bibr26-10732748231193243"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lasisi</surname><given-names>F</given-names></name><name name-style="western"><surname>Mouchli</surname><given-names>A</given-names></name><name name-style="western"><surname>Riddell</surname><given-names>R</given-names></name></person-group>. <article-title>Agreement in interpreting villous elements and dysplasia in adenomas less than one centimetre in size</article-title>. <source>Dig Liver Dis</source>. <year>2013</year>;<volume>45</volume>(<issue>12</issue>):<fpage>1049</fpage>-<lpage>1055</lpage>.<pub-id pub-id-type="pmid">23871251</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.dld.2013.05.014</pub-id></mixed-citation></ref><ref id="bibr27-10732748231193243"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ponugoti</surname><given-names>PL</given-names></name><name name-style="western"><surname>Cummings</surname><given-names>OW</given-names></name><name name-style="western"><surname>Rex</surname><given-names>DK</given-names></name></person-group>. <article-title>Risk of cancer in small and diminutive colorectal polyps</article-title>. <source>Dig Liver Dis</source>. <year>2017</year>;<volume>49</volume>(<issue>1</issue>):<fpage>34</fpage>-<lpage>37</lpage>.<pub-id pub-id-type="pmid">27443490</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.dld.2016.06.025</pub-id></mixed-citation></ref><ref id="bibr28-10732748231193243"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dube</surname><given-names>C</given-names></name><name name-style="western"><surname>Yakubu</surname><given-names>M</given-names></name><name name-style="western"><surname>McCurdy</surname><given-names>BR</given-names></name></person-group>. <article-title>Risk of advanced adenoma, colorectal cancer, and colorectal cancer mortality in people with low-risk adenomas at baseline colonoscopy: a systematic review and Meta-analysis</article-title>. <source>Am J Gastroenterol</source>. <year>2017</year>;<volume>112</volume>(<issue>12</issue>):<fpage>1790</fpage>-<lpage>1801</lpage>.<pub-id pub-id-type="pmid">29087393</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ajg.2017.360</pub-id></mixed-citation></ref><ref id="bibr29-10732748231193243"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galuppini</surname><given-names>F</given-names></name><name name-style="western"><surname>Fassan</surname><given-names>M</given-names></name><name name-style="western"><surname>Mastracci</surname><given-names>L</given-names></name></person-group>. <article-title>The histomorphological and molecular landscape of colorectal adenomas and serrated lesions</article-title>. <source>Pathologica</source>. <year>2021</year>;<volume>113</volume>(<issue>3</issue>):<fpage>218</fpage>-<lpage>229</lpage>.<pub-id pub-id-type="pmid">34294939</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.32074/1591-951X-270</pub-id><pub-id pub-id-type="pmcid">PMC8299322</pub-id></mixed-citation></ref><ref id="bibr30-10732748231193243"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rex</surname><given-names>DK</given-names></name><name name-style="western"><surname>Ahnen</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Baron</surname><given-names>JA</given-names></name></person-group>. <article-title>Serrated lesions of the colorectum: review and recommendations from an expert panel</article-title>. <source>Am J Gastroenterol</source>. <year>2012</year>;<volume>107</volume>(<issue>9</issue>):<fpage>1315</fpage>-<lpage>1329</lpage>. <comment>quiz 1314, 1330</comment>.<pub-id pub-id-type="pmid">22710576</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ajg.2012.161</pub-id><pub-id pub-id-type="pmcid">PMC3629844</pub-id></mixed-citation></ref><ref id="bibr31-10732748231193243"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdeljawad</surname><given-names>K</given-names></name><name name-style="western"><surname>Vemulapalli</surname><given-names>KC</given-names></name><name name-style="western"><surname>Kahi</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Cummings</surname><given-names>OW</given-names></name><name name-style="western"><surname>Snover</surname><given-names>DC</given-names></name><name name-style="western"><surname>Rex</surname><given-names>DK</given-names></name></person-group>. <article-title>Sessile serrated polyp prevalence determined by a colonoscopist with a high lesion detection rate and an experienced pathologist</article-title>. <source>Gastrointest Endosc</source>. <year>2015</year>;<volume>81</volume>(<issue>3</issue>):<fpage>517</fpage>-<lpage>524</lpage>.<pub-id pub-id-type="pmid">24998465</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.gie.2014.04.064</pub-id></mixed-citation></ref><ref id="bibr32-10732748231193243"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Je</surname><given-names>IJ</given-names></name><name name-style="western"><surname>de Wit</surname><given-names>K</given-names></name><name name-style="western"><surname>van der Vlugt</surname><given-names>M</given-names></name><name name-style="western"><surname>Bastiaansen</surname><given-names>BA</given-names></name><name name-style="western"><surname>Fockens</surname><given-names>P</given-names></name><name name-style="western"><surname>Dekker</surname><given-names>E</given-names></name></person-group>. <article-title>Prevalence, distribution and risk of sessile serrated adenomas/polyps at a center with a high adenoma detection rate and experienced pathologists</article-title>. <source>Endoscopy</source>. <year>2016</year>;<volume>48</volume>(<issue>8</issue>):<fpage>740</fpage>-<lpage>746</lpage>.<pub-id pub-id-type="pmid">27110696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-0042-105436</pub-id></mixed-citation></ref><ref id="bibr33-10732748231193243"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bordacahar</surname><given-names>B</given-names></name><name name-style="western"><surname>Barret</surname><given-names>M</given-names></name><name name-style="western"><surname>Terris</surname><given-names>B</given-names></name></person-group>. <article-title>Sessile serrated adenoma: from identification to resection</article-title>. <source>Dig Liver Dis</source>. <year>2015</year>;<volume>47</volume>(<issue>2</issue>):<fpage>95</fpage>-<lpage>102</lpage>.<pub-id pub-id-type="pmid">25445408</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.dld.2014.09.006</pub-id></mixed-citation></ref><ref id="bibr34-10732748231193243"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Woolfrey</surname><given-names>J</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>SF</given-names></name></person-group>. <article-title>Diagnosis and predictors of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare setting</article-title>. <source>Gastrointest Endosc</source>. <year>2018</year>;<volume>87</volume>(<issue>3</issue>):<fpage>755</fpage>-<lpage>765</lpage>. <comment>e1</comment>.<pub-id pub-id-type="pmid">28843582</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.gie.2017.08.012</pub-id></mixed-citation></ref></ref-list><app-group><app id="app1-10732748231193243"><label>Appendix</label><sec><title>Abbreviations</title><def-list><def-item><term id="G1-10732748231193243">AADR</term><def><p>Advanced adenoma detection rate</p></def></def-item><def-item><term id="G2-10732748231193243">ADR</term><def><p>Adenoma detection rate</p></def></def-item><def-item><term id="G3-10732748231193243">CRC</term><def><p>Colorectal cancer</p></def></def-item><def-item><term id="G4-10732748231193243">IQR</term><def><p>Interquartile range</p></def></def-item><def-item><term id="G5-10732748231193243">PDR</term><def><p>Polyp detection rate</p></def></def-item><def-item><term id="G6-10732748231193243">SSLs</term><def><p>Sessile serrated lesions</p></def></def-item></def-list></sec></app></app-group></back></article></pmc-articleset>